Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 83, Issue 3

Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression No Access

Abstract

The adeno-associated virus type 2 (AAV-2) Rep proteins are essential for AAV DNA replication and regulation of AAV gene expression. We have identified a cellular protein interacting with Rep78 and Rep68 in yeast two-hybrid analysis and in GST pull-down assays. This protein has recently been described as both a p53 (p53BP3) and a topoisomerase I interacting protein (Topors). It contains an arginine/serine-rich domain, a RING finger domain and five PEST sequences. A minimal sequence sufficient for interaction with Rep was mapped to Topors amino acids 871 to 917. We show that the same region is also involved in the interaction with p53. Rep sequences involved in interaction with Topors were mapped to Rep amino acids 172 to 481. Overexpression of Topors stimulated AAV gene expression in the absence of helper virus, suggesting a function of Topors as a transcriptional regulator.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-3-511
2002-03-01
2025-01-20
Loading full text...

Full text loading...

References

  1. Batchu R. B., Hermonat P. L. 1995; The trans-inhibitory Rep78 protein of adeno-associated virus binds to TAR region DNA of the human immunodeficiency virus type 1 long terminal repeat. FEBS Letters 367:267–271
     [Google Scholar]
  2. Batchu R. B., Kotin R. M., Hermonat P. L. 1994; The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter. Cancer Letters 86:23–31
     [Google Scholar]
  3. Batchu R. B., Shammas M. A., Wang J. Y., Munshi N. C. 1999; Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition. Cancer Research 59:3592–3595
     [Google Scholar]
  4. Beaton A., Palumbo P., Berns K. I. 1989; Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. Journal of Virology 63:4450–4454
     [Google Scholar]
  5. Berns K. I., Linden R. M. 1995; The cryptic life style of adeno-associated virus. Bioessays 17:237–245
     [Google Scholar]
  6. Chiorini J. A., Zimmermann B., Yang L., Smith R. H., Ahearn A., Herberg F., Kotin R. M. 1998; Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Molecular and Cellular Biology 18:5921–5929
     [Google Scholar]
  7. Costello E., Saudan P., Winocour E., Pizer L., Beard P. 1997; High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression. EMBO Journal 16:5943–5954
     [Google Scholar]
  8. de la Maza L. M., Carter B. J. 1981; Inhibition of adenovirus oncogenicity in hamsters by adeno-associated virus DNA. Journal of the National Cancer Institute 67:1323–1326
     [Google Scholar]
  9. Di Pasquale G., Stacey S. N. 1998; Adeno-associated virus Rep78 protein interacts with protein kinase A and its homologue PRKX and inhibits CREB-dependent transcriptional activation. Journal of Virology 72:7916–7925
     [Google Scholar]
  10. Everett R., O’Hare P., O’Rourke D., Barlow P., Orr A. 1995; Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. Journal of Virology 69:7339–7344
     [Google Scholar]
  11. Freemont P. S. 2000; RING for destruction?. Current Biology 10:R84–R87
     [Google Scholar]
  12. Fu X. D. 1995; The superfamily of arginine/serine-rich splicing factors. RNA 1:663–680
     [Google Scholar]
  13. Georgiev O., Bourquin J. P., Gstaiger M., Knoepfel L., Schaffner W., Hovens C. 1996; Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localization of expressed proteins. Gene 168:165–167
     [Google Scholar]
  14. Haluska P. Jr, Saleem A., Rasheed Z., Ahmed F., Su E. W., Liu L. F., Rubin E. H. 1999; Interaction between human topoisomerase I and a novel RING finger/arginine–serine protein. Nucleic Acids Research 27:2538–2544
     [Google Scholar]
  15. Heilbronn R., Burkle A., Stephan S., zur Hausen H. 1990; The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. Journal of Virology 64:3012–3018
     [Google Scholar]
  16. Hermonat P. L. 1989; The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 172:253–261
     [Google Scholar]
  17. Hermonat P. L. 1994; Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Letters 81:129–136
     [Google Scholar]
  18. Hermonat P. L., Santin A. D., Batchu R. B., Zhan D. 1998; The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA-binding protein in vitro and in vivo . Virology 245:120–127
     [Google Scholar]
  19. Horer M., Weger S., Butz K., Hoppe-Seyler F., Geisen C., Kleinschmidt J. A. 1995; Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. Journal of Virology 69:5485–5496
     [Google Scholar]
  20. Im D. S., Muzyczka N. 1990; The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61:447–457
     [Google Scholar]
  21. Iwabuchi K., Li B., Bartel P., Fields S. 1993; Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. Oncogene 8:1693–1696
     [Google Scholar]
  22. Khleif S. N., Myers T., Carter B. J., Trempe J. P. 1991; Inhibition of cellular transformation by the adeno-associated virus rep gene. Virology 181:738–741
     [Google Scholar]
  23. Ko L. J., Prives C. 1996; p53: puzzle and paradigm. Genes & Development 10:1054–1072
     [Google Scholar]
  24. Kyostio S. R., Owens R. A., Weitzman M. D., Antoni B. A., Chejanovsky N., Carter B. J. 1994; Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. Journal of Virology 68:2947–2957
     [Google Scholar]
  25. Kyostio S. R., Wonderling R. S., Owens R. A. 1995; Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. Journal of Virology 69:6787–6796
     [Google Scholar]
  26. Labow M. A., Hermonat P. L., Berns K. I. 1986; Positive and negative autoregulation of the adeno-associated virus type 2 genome. Journal of Virology 60:251–258
     [Google Scholar]
  27. Labow M. A., Graf L. H. Jr, Berns K. I. 1987; Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Molecular and Cellular Biology 7:1320–1325
     [Google Scholar]
  28. Lium E. K., Silverstein S. 1997; Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential alpha27 gene. Journal of Virology 71:8602–8614
     [Google Scholar]
  29. Lorick K. L., Jensen J. P., Fang S., Ong A. M., Hatakeyama S., Weissman A. M. 1999; RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proceedings of the National Academy of Sciences, USA 96:11364–11369
     [Google Scholar]
  30. McCarty D. M., Christensen M., Muzyczka N. 1991; Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. Journal of Virology 65:2936–2945
     [Google Scholar]
  31. Mendelson E., Trempe J. P., Carter B. J. 1986; Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. Journal of Virology 60:823–832
     [Google Scholar]
  32. Muramatsu S.-i., Handa A., Kajigaya S., Brown K. E. 1998; Transcription-positive cofactor 4 enhances rescue of adeno-associated virus genome from an infectious clone. Journal of General Virology 79:2157–2161
     [Google Scholar]
  33. Murphy M., Hinman A., Levine A. J. 1996; Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes & Development 10:2971–2980
     [Google Scholar]
  34. Pereira D. J., Muzyczka N. 1997a; The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation. Journal of Virology 71:4300–4309
     [Google Scholar]
  35. Pereira D. J., Muzyczka N. 1997b; The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. Journal of Virology 71:1747–1756
     [Google Scholar]
  36. Pereira D. J., McCarty D. M., Muzyczka N. 1997; The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. Journal of Virology 71:1079–1088
     [Google Scholar]
  37. Raj K., Ogston P., Beard P. 2001; Virus-mediated killing of cells that lack p53 activity. Nature 412:914–917
     [Google Scholar]
  38. Rechsteiner M., Rogers S. W. 1996; PEST sequences and regulation by proteolysis. Trends in Biochemical Sciences 21:267–271
     [Google Scholar]
  39. Srivastava A., Lusby E. W., Berns K. I. 1983; Nucleotide sequence and organization of the adeno-associated virus 2 genome. Journal of Virology 45:555–564
     [Google Scholar]
  40. Tratschin J. D., Miller I. L., Carter B. J. 1984; Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. Journal of Virology 51:611–619
     [Google Scholar]
  41. Tratschin J. D., Tal J., Carter B. J. 1986; Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Molecular and Cellular Biology 6:2884–2894
     [Google Scholar]
  42. Trempe J. P., Carter B. J. 1988; Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation. Journal of Virology 62:68–74
     [Google Scholar]
  43. Weger S., Wistuba A., Grimm D., Kleinschmidt J. A. 1997; Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. Journal of Virology 71:8437–8447
     [Google Scholar]
  44. Weger S., Wendland M., Kleinschmidt J. A., Heilbronn R. 1999; The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. Journal of Virology 73:260–269
     [Google Scholar]
  45. Wistuba A., Weger S., Kern A., Kleinschmidt J. A. 1995; Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. Journal of Virology 69:5311–5319
     [Google Scholar]
  46. Yang Q., Kadam A., Trempe J. P. 1992; Mutational analysis of the adeno-associated virus rep gene. Journal of Virology 66:6058–6069
     [Google Scholar]
  47. Yang Q., Chen F., Ross J., Trempe J. P. 1995; Inhibition of cellular and SV40 DNA replication by the adeno-associated virus Rep proteins. Virology 207:246–250
     [Google Scholar]
  48. Zahler A. M., Lane W. S., Stolk J. A., Roth M. B. 1992; SR proteins: a conserved family of pre-mRNA splicing factors. Genes & Development 6:837–847
     [Google Scholar]
  49. Zhou R., Wen H., Ao S. Z. 1999; Identification of a novel gene encoding a p53-associated protein. Gene 235:93–101
     [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-83-3-511
Loading
Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression
J. Gen. Virol. 83, 511 (2002); https://doi.org/10.1099/0022-1317-83-3-511
/content/journal/jgv/10.1099/0022-1317-83-3-511
/content/journal/jgv/10.1099/0022-1317-83-3-511
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error